| Literature DB >> 29943774 |
Laura Flores-Cisneros1,2, Denisse Castro-Eguiluz3, Diana Yolanda Reyes-Barretero4, Emigdio Jaimes4, Claudia Cano-Blanco1, Carlos Avendaño-Pérez5, Berenice Carbajal-López1, Miriam Sánchez-López1, Aida Mota-García1, Dolores Gallardo-Rincón1, Marce Inzunza-Soto6, Claudia Hernandez-Quintero6, Lucely Cetina-Pérez1.
Abstract
Radiotherapy is a fundamental part of the treatment of pelvic neoplasms. Up to 90% of patients develop gastrointestinal symptoms as a result of acute injury to the small and large intestine, particularly in the mucosa. Radiotherapy leads to atrophy of the intestinal epithelium, acute crypt inflammation, inflammatory infiltration of the epithelium, malabsorption of lactose, and biliary salts as well as alterations in pancreatic enzymes and biliary salts, resulting in the malabsorption syndrome and dysbiosis. The most commonly reported symptoms of pelvic radiation disease include changes in bowel habits (94%), decreased fecal consistency (80%), frequency of bowel movements (74%), bowel urgency (39%), and fecal incontinence (37%). Although nutritional interventions with dietary modifications have been reported to prevent and treat gastrointestinal symptoms, the evidence remains inconclusive. Copyright:Entities:
Keywords: Chemotherapy; Diet; Fat; Fiber; Gastrointestinal toxicity; Lactose; Pelvic cancer; Radiotherapy
Mesh:
Year: 2018 PMID: 29943774 DOI: 10.24875/RIC.18002525
Source DB: PubMed Journal: Rev Invest Clin ISSN: 0034-8376 Impact factor: 1.451